The rational combination of BRAF inhibition with immunotherapy for the treatment of metastatic melanoma

被引：0
|
作者：
Lizee, Gregory [1 ]
Liu, Chengwen [1 ]
Hwu, Patrick [1 ]
机构：
[1] UT MD Anderson Canc Ctr, Houston, TX USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-PL03-03
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PL03-03
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Non-BRAF-targeted therapy, immunotherapy, and combination therapy for melanoma
    Tomei, Sara
    Wang, Ena
    Delogu, Lucia Gemma
    Marincola, Francesco M.
    Bedognetti, Davide
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (05) : 663 - 686
  • [32] Treatment response under BRAF/MEK inhibition in metastatic malignant melanoma with BRAF L597R mutation
    Moufarrej, A.
    Lindhof, H. H.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 88 - 88
  • [33] BRAF inhibition by vemurafenib in combination with temozolomide or fotemustine in melanoma cells
    Roos, W.
    Quiros, S.
    Krumm, A.
    Merz, S.
    Switzeny, O.
    Christmann, M.
    Loquai, C.
    Kaina, B.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 : 27 - 27
  • [34] Dabrafenib and Trametinib, Alone and in Combination for BRAF-Mutant Metastatic Melanoma
    Menzies, Alexander M.
    Long, Georgina V.
    CLINICAL CANCER RESEARCH, 2014, 20 (08) : 2035 - 2043
  • [35] Patterns of BRAF testing and treatment in patients with metastatic melanoma presumed BRAF positive
    Ghate, Sameer
    Nakasato, Antonio
    Ionescu-Ittu, Raluca
    Shi, Sherry
    Ndife, Briana
    Burne, Rebecca
    Laliberte, Francois
    Duh, Mei Sheng
    CANCER RESEARCH, 2018, 78 (13)
  • [36] Adoption of Immunotherapy in the Treatment of Metastatic Malignant Melanoma
    Pezzi, Todd A.
    Pezzi, Ashley
    Shreders, Amanda
    Hammond, William
    Crozier, Jennifer
    Pezzi, Christopher
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (10): : S115 - S116
  • [37] Checkpoint immunotherapy by nivolumab for treatment of metastatic melanoma
    Koppolu, Veerendra
    Vasigala, Veneela Krishna Rekha
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 (06) : 1167 - 1175
  • [38] Outcomes of Patients With Metastatic Melanoma Treated With Immunotherapy Prior to or After BRAF Inhibitors
    Ackerman, Allison
    Klein, Oliver
    McDermott, David F.
    Wang, Wei
    Ibrahim, Nageatte
    Lawrence, Donald P.
    Gunturi, Anasuya
    Flaherty, Keith T.
    Hodi, F. Stephen
    Kefford, Richard
    Menzies, Alexander M.
    Atkins, Michael B.
    Long, Georgina V.
    Sullivan, Ryan J.
    CANCER, 2014, 120 (11) : 1695 - 1701
  • [39] Headache in the Setting of Immunotherapy Treatment for Metastatic Melanoma
    Comstock, Dawn E.
    Nishino, Mizuki
    Giardino, Angela A.
    JAMA ONCOLOGY, 2017, 3 (05) : 703 - 704
  • [40] SEQUENTIAL CHEMOTHERAPY AND IMMUNOTHERAPY FOR THE TREATMENT OF METASTATIC MELANOMA
    SCHUCHTER, LM
    WOHLGANGER, JA
    FISHMAN, EK
    MACDERMOTT, ML
    MCGUIRE, WP
    JOURNAL OF IMMUNOTHERAPY, 1992, 12 (04): : 272 - 276
12345